Cd. Swerdlow et al., Detection of atrial fibrillation and flutter by a dual-chamber implantablecardioverter-defibrillator, CIRCULATION, 101(8), 2000, pp. 878-885
Citations number
12
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-To distinguish prolonged episodes of atrial fibrillation (AF) th
at require cardioversion from self-terminating episodes that do not, an atr
ial implantable cardioverter-defibrillator (ICD) must be able to detect AF
continuously for extended periods, The ICD should discriminate between atri
al tnc tachycardia/flutter (AT), which may be terminated by antitachycardia
pacing, and AF, which requires cardioversion.
Methods and Results-We studied 80 patients with AT/AF and ventricular arrhy
thmias who were treated with a new atrial/dual-chamber ICD. During a follow
-up period lasting 6 +/- 2 months, we validated spontaneous, device-defined
AT/AF episodes by stored electrograms in all patients, In 58 patients, we
performed 80 Holter recordings with telemetered atrial electrograms, both t
o validate the continuous detection of AT/AF and to determine the sensitivi
ty of the detection of AT/AF. Detection was appropriate in 98% of 132 AF ep
isodes and 88% of 190 AT episodes (98% of 128 AT episodes with an atrial cy
cle length <300 ms). Intermittent sensing of far-field R waves during sinus
tachycardia caused 27 inappropriate AT/AF detections: these detections las
ted 2.6 +/- 2.0 minutes. AT/AF was detected continuously in 27 of 28 patien
ts who had spontaneous episodes of AT/AF (96%). The device memory recorded
90 appropriate AT/AF episodes lasting >1 hour, for a total of 2697 hours of
continuous detection of AT/AF. During Holter monitoring, the sensitivity o
f the detection of AT/AF (116 hours) was 100%; the specificity of the detec
tion of non-AT/AF rhythms (1290 hours) was 99.99%. Of 166 appropriate episo
des detected as AT, 45% were terminated by antitachycardia pacing.
Conclusions-A new ICD detects AT/AF accurately and continuously. Therapy ma
y be programmed for long-duration AT/AF, with a low risk of underdetecrion.
Discrimination of AT from AF permits successful pacing therapy for a signi
ficant fraction of AT.